What titration is actually solving
Starting at a full dose would produce avoidable nausea and dropouts. Starting low and stepping up lets the gut adapt while the clinician watches how you respond. The schedule is a tolerance strategy first and an efficacy strategy second.
Why an internet chart is dangerous here
Compounded preparations differ in concentration between pharmacies, so the same number of units can be a very different amount of drug. FDA has warned about dosing errors with compounded GLP-1 products for exactly this reason: people converting between charts, syringes and routes without clinical input.
What your label actually tells you
Your dose, your interval, your concentration, your discard date, and the pharmacy to call. It is the only dosing document that applies to your vial. If it conflicts with anything you read, the label wins and the pharmacy answers questions.
Tirzepatide activates both the GIP and the GLP-1 receptor – two gut-hormone pathways, not one.
When a step up gets delayed
If tolerability is poor, a clinician may hold you at a dose longer, or step back. That is normal practice, not failure. Rushing the schedule to chase results is how people end up unable to eat.
What to report before each step
Nausea severity and timing, vomiting, reflux, constipation, appetite extremes, and anything that stopped you eating or drinking normally. That information is what makes the next decision safe. See the 30-second film answers for this medication.
What actually happens in a telehealth evaluation
A legitimate telehealth pathway has a defined sequence, and knowing it is the easiest way to spot one that does not. You complete an intake covering medical history, current medications, allergies, and relevant measurements. A clinician licensed in your state reviews it. They may ask follow-up questions, request labs, or decline. If they judge treatment appropriate, they write a prescription, and a licensed pharmacy dispenses and ships it. The parts that matter are that a real licensed clinician makes the decision, that declining is a genuine possible outcome, and that no payment obligates a prescription. What happens in an online visit walks through it, and questions to ask your clinician lists what to bring.
FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed.
How to tell a legitimate pharmacy from a grey-market seller
The reliable signals are structural rather than cosmetic. A legitimate operation requires a medical evaluation before prescribing, names the dispensing pharmacy and its state licensure, provides a way to reach a clinician after you start, and states plainly that compounded medications are not FDA-approved. The warning signs are equally consistent: no intake or a token questionnaire nobody reviews, no named pharmacy, prescription medication sold without a prescription, research-use-only or not-for-human-use labelling, claims of guaranteed results, and pressure tactics around expiring discounts. FDA has warned specifically about unapproved GLP-1 products sold online. Red flags when buying online expands the checklist, and choosing a telehealth programme covers what to compare.
What cash-pay pricing means in practice
Cash-pay means the price is the price: no insurance adjudication, no formulary, no prior authorisation, and no explanation of benefits arriving weeks later. PinwellRx does not accept insurance. The trade-off is real in both directions. You lose any possibility of reimbursement, and compounded preparations are generally not covered anyway. You gain a predictable number and no coverage gatekeeping. When comparing providers, normalise for supply length, whether the clinician visit and follow-ups are included, and whether shipping and injection supplies are extra. Insurance and compounded medications explains the coverage picture, and the cheapest route without insurance compares approaches without promising a result.
A clinician reviews your intake and gives you a real answer, not another article.
Frequently asked questions
Can I increase my own dose?
No. Dose changes are clinical decisions, and self-titration is a documented source of serious dosing errors with compounded products.
Why is my schedule different from a friend's?
Different concentrations, histories, tolerability and clinical judgment. Two correct plans can look nothing alike.
Can I get a GLP-1 online?
Yes, through a telehealth pathway where a clinician licensed in your state reviews an intake and decides whether treatment is appropriate. A prescription is never guaranteed, and a clinician can decline.
What is the cheapest GLP-1 without insurance?
Cash-pay pricing varies by preparation, supply length, and what the quoted price includes. Compare on a normalised basis: supply length, whether visits are included, and whether shipping and supplies are extra.
Does insurance cover compounded medications?
Compounded preparations are generally not covered by insurance. PinwellRx does not accept insurance and publishes flat cash pricing.
How do I choose a telehealth provider safely?
Look for a required medical evaluation, a named and state-licensed dispensing pharmacy, access to a clinician after you start, and plain statements that compounded medications are not FDA-approved.
Get a schedule that is actually yours
A licensed clinician sets it after reviewing your history. Rx only, refunded if you are not prescribed.
Rx only. A licensed clinician decides whether treatment is appropriate and may determine that no treatment, or a different treatment, is right for you. Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing. Individual results vary.
Sources
Clinical trials listed below evaluated FDA-approved products at the doses studied. They are cited as published science, not as evidence about any compounded preparation, which is not FDA-approved and has not been evaluated by FDA for safety, effectiveness, or quality.
- FDAFDA: Alerts health care providers, compounders and patients of dosing errors associated with compounded semaglutide injectable products
- Peer-reviewedJastreboff AM et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med 2022;387:205-216
- FDA guidanceFDA: Compounding and the FD&C Act, Section 503A
- FDA guidanceFDA: BeSafeRx, buying medicine online safely
Spotted something inaccurate? Report an error – corrections are logged per our editorial standards.
More on Compounded Tirzepatide
Same medication, different question.
